Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01819116 · ClinicalTrials.gov registry record
Organ Donor Tissue Oxygen Saturation as a Predictor of Number of Organs to Transplant Per Donor
A clinical trial of Brain Death, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- 60
- Enrollment target
- 1
- Study location
NCT01819116 is a study of Brain Death that has completed, run by The Cleveland Clinic. The registered enrollment target is 60 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01819116, a study of Brain Death, has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to quantify the association between tissue oxygen saturation (StO2) during the donor management phase of the Death by Neurological Criteria (DNC) organ donor and the number of organs transplanted per donor.
Conditions Studied
Study Locations (1)
Ohio
- Cleveland Clinic - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2013-04 |
| Est. Completion | 2014-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01819116
The ClinicalTrials.gov registry entry for NCT01819116 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Brain Death appearing as the primary indexed condition, and to 0 interventions.
NCT01819116 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT01819116 about?
NCT01819116 is a clinical study titled "Organ Donor Tissue Oxygen Saturation as a Predictor of Number of Organs to Transplant Per Donor". The objective of this study is to quantify the association between tissue oxygen saturation (StO2) during the donor management phase of the Death by Neurological Criteria (DNC) organ donor and the number of organs transplanted per donor.
What is the current status of trial NCT01819116?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2013-04. Estimated completion is 2014-03.
What conditions does trial NCT01819116 study?
This clinical trial studies the following conditions: Brain Death.
Who is sponsoring clinical trial NCT01819116?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01819116 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Brain Death
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.